CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, alpha-lipoic acid analogue CPI-613 has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity.

June 21, 2017

prudect name : CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, alpha-lipoic acid analogue CPI-613 has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity.
CPI-613

Synonyms: 6,8-bis(benzylthio)octanoic acidCAS NO: 95809-78-2Molecular Formula: C₂₂H₂₈O₂S₂Molecular Weight: 388.59Purity: 99% minSolubility: In DMSOStorage: −20°C

BAY 73-4506 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18508809